Chronic ulcer treated with 10% papain gel by Family Health Strategy: experience report
DOI:
https://doi.org/10.5712/rbmfc12(39)1355Keywords:
Papain. Leg Ulcer. Wound Healing. Primary Health CareAbstract
Lower body ulcers are a public health problem due to the significant incidence, high cost and frequent recurrence. Often, the Family Strategy Unit team provides first contact care with the ulcer carrier, so is a requirement for the team to be updated about treatment options. A topical product used for treatment of cutaneous ulcers is 10% papain gel, due to its antibacterial and debridant characteristics of necrotic tissues and the promotion of tissue renovation. This report describes the experience of Family Strategy Unit team using 10% papain gel in the treatment of cutaneous ulcers, which regressed after thirty days of this use, with emphasis on the support by the specialist for the resolution of the case.
Downloads
Metrics
References
Abbade LP, Lastória S. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol. 2005;44(6):449-56. DOI: http://dx.doi.org/10.1111/j.1365-4632.2004.02456.x DOI: https://doi.org/10.1111/j.1365-4632.2004.02456.x
Prochnow AG, Carneiro M, Ethur ABM. Aplicação tópica de papaína em úlceras cutâneas de pessoas com diabetes. Nursing (São Paulo). 2000;3(27):26-9.
Brasil. Ministério da Saúde. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Área Técnica de Dermatologia Sanitária. Manual de Condutas para Úlceras Neurotróficas e Traumáticas. Brasília: Ministério da Saúde; 2002.
Rodrigues ALS, Oliveira BGRB, Futuro DO, Secoli SR. Efetividade do gel de papaína no tratamento de úlceras venosas: ensaio clínico randomizado. Rev Latino-Am Enfermagem. 2015;23(3):458-65. DOI: http://dx.doi.org/10.1590/0104-1169.0381.2576 DOI: https://doi.org/10.1590/0104-1169.0381.2576
Malaquias SG, Bachion MM, Sant’ana SM, Dallarmi CC, Lino Junior Rde S, Ferreira PS. People with vascular ulcers in outpatient nursing care: a study of sociodemographic and clinical variables. Rev Esc Enferm USP. 2012;46(2):302-10. DOI: http://dx.doi.org/10.1590/S0080-62342012000200006 DOI: https://doi.org/10.1590/S0080-62342012000200006
Dias TYAF, Costa IKF, Salvetti MG, Mendes CKTT, Torres GGV. Influences of health care services and clinical characteristics on the quality of life of patients with venous ulcer. Acta Paul Enferm. 2013;26(6):529-34. DOI: http://dx.doi.org/10.1590/S0103-21002013000600004 DOI: https://doi.org/10.1590/S0103-21002013000600004
Ribeiro APL, Oliveira BGRB, Soares MF, Barreto BMF, Futuro DO, Castilho SR. Efetividade dos géis de papaína a 2% e 4% na cicatrização de úlceras venosas. Rev Esc Enferm USP. 2015;49(3):395-402. DOI: http://dx.doi.org/10.1590/S0080-623420150000300006 DOI: https://doi.org/10.1590/S0080-623420150000300006
Leite AP, Oliveira BGRB, Soares MF, Barrocas DLR. Uso e efetividade da papaína no processo de cicatrização de feridas: uma revisão sistemática. Rev Gaúcha Enferm. 2012;33(3):198-207. DOI: http://dx.doi.org/10.1590/S1983-14472012000300026 DOI: https://doi.org/10.1590/S1983-14472012000300026
Ferreira AM, Oliveira KA, Vieira LC, Rol JL. Revisão de estudos clínicos de enfermagem: utilização de papaína para o tratamento de feridas. Rev Enferm UERJ. 2005;13(3):382-9.
Brito LC Jr, Ferreira PL. Cicatrização de feridas contaminadas tratadas com papaína. Medicina (Ribeirão Preto). 2015;48(2):168-74. DOI: http://dx.doi.org/10.11606/issn.2176-7262.v48i2p168-174 DOI: https://doi.org/10.11606/issn.2176-7262.v48i2p168-174
Araújo IC, Defune E, Abbade LP, Miot HA, Bertanha M, Carvalho LR, et al. Fibrin gel versus papain gel in the healing of chronic venous ulcers: A double-blind randomized controlled trial. Phlebology. 2016 Oct 4. [Epub ahead of print]
Monetta L. O uso da papaína nos curativos feitos pela enfermagem. Rev Bras Enferm. 1987;40(1):66-73. DOI: http://dx.doi.org/10.1590/S0034-71671987000100012 DOI: https://doi.org/10.1590/S0034-71671987000100012
Downloads
Published
How to Cite
Issue
Section
License
By submitting a manuscript to the RBMFC, authors retain ownership of the copyright in the article, and authorize RBMFC to publish that manuscript under the Creative Commons Attribution 4.0 license and identify itself as the vehicle of its original publication.
